| Date Filed | Type | Description |
| 10/12/2023 |
10-Q
| Quarterly Report for the period ended August 31, 2023 |
| 10/12/2023 |
8-K
| Quarterly results |
| 08/25/2023 |
8-K
| Other Events Interactive Data |
| 07/14/2023 |
10-Q
| Quarterly Report for the period ended May 31, 2023 |
| 04/21/2023 |
10-Q
| Quarterly Report for the period ended February 28, 2023 |
| 04/14/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 03/09/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 02/03/2023 |
RW
| Form RW - Registration Withdrawal Request: |
| 12/29/2022 |
8-K
| Quarterly results |
| 10/05/2022 |
8-K
| Quarterly results |
| 09/16/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/29/2022 |
CERT
| Form CERT - Certification by an exchange approving securities for listing: |
| 08/29/2022 |
8-A12B
| Form 8-A12B - Registration of securities [Section 12(b)]: |
| 08/23/2022 |
8-K
| Other Events Interactive Data |
| 07/22/2022 |
8-K
| Quarterly results |
| 07/11/2022 |
10-Q
| Quarterly Report for the period ended May 31, 2022 |
| 04/27/2022 |
10-Q/A
| Quarterly Report for the period ended February 28, 2022 [amend] |
| 04/13/2022 |
10-Q
| Quarterly Report for the period ended February 28, 2022 |
| 04/04/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 03/16/2022 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"PURCHASE AGREEMENTBETWEEN",
"CORD BLOOD BANKING LEADER CRYO-CELL ANNOUNCES EXTRAVAULT BIOREPOSITORY SERVICE OLDSMAR, FL – March 16, 2022 – Cryo-Cell International, Inc. , the world’s first private cord blood bank to separate and store stem cells in 1992, announces it has entered into a purchase contract, with the closing subject to customary conditions, for a newly constructed, 56,000 sq ft facility located in the Regional Commerce Center within the Research Triangle, NC. We anticipate this facility will expand Cryo-Cell’s cryopreservation and cold storage business by introducing a new service, ExtraVault . With over 30 years of experience in handling biological specimens for both research and clinical use, Cryo-Cell intends to leverage this expertise and offer these biorepository services to biopharmaceutical compani..." |
|
| 02/24/2022 |
8-K
| Quarterly results |
| 02/22/2022 |
10-K
| Annual Report for the period ended November 30, 2021 |
| 02/14/2022 |
SC 13G/A
| ISZO CAPITAL LP reports a 5.7% stake in Cryo-Cell International, Inc. |
| 01/25/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 12/15/2021 |
8-K
| Quarterly results |
| 10/25/2021 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 10/15/2021 |
10-Q
| Quarterly Report for the period ended August 31, 2021 |
| 10/15/2021 |
8-K
| Quarterly results |
| 10/01/2021 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 09/22/2021 |
8-K
| Quarterly results |
| 08/30/2021 |
CERT
| Form CERT - Certification by an exchange approving securities for listing: |
| 08/27/2021 |
8-A12B
| Form 8-A12B - Registration of securities [Section 12(b)]: |
| 08/04/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/19/2021 |
8-K
| Quarterly results |
|